Scholarly publications and presentations by Rochester Regional Health's Oncology and Hematology department authors.
Submissions from 2022
9-2022 P2.10-02 EMERGE 402: Preliminary Real-world Characteristics and Safety of Lurbinectedin in Patients With Small-cell Lung Cancer, Peter W. Bushunow, Rochester Regional Health and Shaker R. Dakhil, Wichita CCOP, Wichita, KS
8-16-2022 Targeted Therapies in Breast Cancer, Vatsala Kirtani, Rochester Regional Health
8-2022 Does a Bleeding Disorder Lessen the Efficacy of the 52-mg Levonorgestrel-Releasing Intrauterine System for Heavy Menstrual Bleeding in Adolescents? A Retrospective Multicenter Study, Misha Khalighi, Children's Hospital Los Angeles, Los Angeles, California, Allison P Wheeler, Vanderbilt University Medical Center, Nashville, Tennessee, Oluyemisi A Adeyemi-Fowode, Texas Children's Hospital, Houston, Texas, et al.
8-2022 Treatment of Light Chain Deposition Disease: A Systematic Review, Adeel Masood, MD Anderson Cancer Center, Houston, TX, Hamid Ehsan, Levine Cancer Institute/Atrium Health, Charlotte, NC, Qamar Iqbal, Tidal Health Peninsula Regional, Salisbury, MD, et al.
7-2022 All catastrophes are not catastrophic antiphospholipid syndrome, Mukul Singal, Rochester Regional Health and Peter Kouides, Rochester Regional Health
6-2022 Outcomes of robotic surgery in morbidly obese patients with endometrial cancer: a retrospective study, Luke J. King, Geisinger Medical Center, Amanda J. Young, Geisinger Medical Center, Preeyanka M. Nagar, Geisinger Medical Center, et al.
5-26-2022 Differentiation Syndrome, Mohammad Ammad-Ud-Din, Rochester Regional Health and Saad Jamshed, Rochester Regional Health
4-28-2022 The Many Faces of HLH: Hemophagocytic Lymphohistiocytosis, Hassan Saeed, Rochester Regional Health and Peter A. Kouides, Rochester Regional Health
3-10-2022 Grand Rounds Case Conference, Robin M. Reid, Rochester Regional Health and Sanjana K. Kashinath, Rochester Regional Health
2-22-2022 Allogeneic Transplantation for Acute Leukemias, Anne S. Renteria, Rochester Regional Health
Submissions from 2021
11-23-2021 Asxl1 Mutation Is a Novel Risk Factor for Bleeding in Patients with Philadelphia-Negative Myeloproliferative Neoplasms (MPN), Amro Elshoury; Han Yu; and Peter A. Kouides, Rochester Regional Health
11-23-2021 Evaluation of Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Immunizations in Patients with B-Cell Malignancies, Mukul Singal, Rochester Regional Health, Sanjana K. Kashinath, Rochester Regional Health, S. Shahzad Mustafa, Rochester Regional Health, et al.
11-23-2021 Spot Protein/Creatinine Ratio as an Alternative for 24-Hour Urine Collection for Proteinuria in Patients with Multiple Myeloma, Saad Jamshed, Rochester Regional Health, Jonathan Bress, Rochester Regional Health, Mohammad Ammad-ud-din, Rochester Regional Health, et al.
11-23-2021 The Von Willebrand Disease Aging and Bleeding Correlation (VWD ABC) Study, Craig D. Seaman; Margaret V. Ragni; and Peter A. Kouides, Rochester Regional Health
11-16-2021 The Myriad of Hematological Challenges of COVID-19 Infection, Peter A. Kouides, Rochester Regional Health
10-28-2021 Autologous Transplantation and CAR-T Cell Therapies for Lymphomas, Simrat Gill, Rochester Regional Health and Anne S. Renteria, Rochester Regional Health
10-18-2021 Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multi-center cohort study, Brian J. Carney, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States., Tzu-Fei Wang, University of Ottawa, The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, Ohio, Canada., Siyang Ren, Dana-Farber Cancer Institute, Boston, Massachusetts, United States., et al.
9-23-2021 The Myriad of Hematological Challenges of COVID-19 Infection, Peter A. Kouides, Rochester Regional Health
9-16-2021 Primary Extranodal NK/T-Cell Lymphoma Presenting as Neurolymphomatosis Involving Multiple Cranial Nerves: A Case Report, Sharmila Ghosh, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Jacques Azzi, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Amy M. Chan, Department of Medical Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA., et al.
9-1-2021 Regulation and importance of factor VIII levels in hemophilia A carriers, Peter H. Cygan, Penn State Health Milton S. Hershey Medical Center and Peter A. Kouides, Rochester Regional Health
8-15-2021 Rare Coagulation Factor Deficiencies (Factors VII, X, V, and II), Glaivy Batsuli, Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta; Department of Pediatrics, Emory University, Atlanta, GA, USA. and Peter Kouides, Rochester Regional Health
8-1-2021 Acquired Hemophilia A in Peripartum Period: Diagnostic and Therapeutic Dilemma, Syed Hamza Bin Waqar, Hematology and Oncology, SUNY Downstate Medical Center, New York, USA., Leen Khoury, Hematology and Oncology, SUNY Downstate Medical Center, New York, USA., Ather Hussain, Rochester Regional Health, et al.
7-1-2021 Management of anticoagulation associated reproductive tract bleeding in adolescent and young adult females - Results of a multinational survey, Madhvi Rajpurkar, Wayne State University, Ayesha Zia, UT Southwestern Medical School, Angela C. Weyand, University of Michigan Medical School, et al.
7-1-2021 Primary thromboprophylaxis in a patient with type 3 von Willebrand disease and severe COVID-19 infection, Anshul Vagrecha, Cohen Children's Medical Center, Joseph Stanco, Cohen Children's Medical Center, Sumreen Majeed, Imbert Cancer Center, et al.
6-1-2021 North American Physician Practice Patterns in the Management of Anticoagulation in Pregnancy, Alice J. Cohen, Newark Beth Israel Medical Center, Lisa Boggio, Rush University Medical Center, Henny H. Billett, Albert Einstein College of Medicine, et al.